Manuela Fantini
Overview
Explore the profile of Manuela Fantini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bongiovanni A, Foca F, Menis J, Stucci S, Artioli F, Guadalupi V, et al.
Front Immunol
. 2021 Dec;
12:697298.
PMID: 34858389
Introduction: Bone metastases (BMs) are a negative prognostic factor in patients with non-small cell lung cancer (NSCLC). Although immune-checkpoint inhibitors (ICIs) have dramatically changed the therapeutic landscape of NSCLC, little...
2.
Bongiovanni A, Foca F, Fantini M, Forcignano M, Artioli F, Berardi R, et al.
Sci Rep
. 2021 Feb;
11(1):4329.
PMID: 33619285
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social...
3.
Tassinari D, Cherubini C, Roudnas B, Tamburini E, Drudi F, Bianchi E, et al.
Rev Recent Clin Trials
. 2018 Apr;
13(3):226-237.
PMID: 29623850
Introduction: To compare the efficacy of abiraterone acetate, enzalutamide, cabazitaxel and Radium-223 in the treatment of castration-resistant, docetaxel-resistant metastatic prostate cancer. Methods: An indirect comparison of Overall Survival (OS) and...
4.
Tassinari D, Cherubini C, Tamburini E, Drudi F, Papi M, Fantini M, et al.
J Chemother
. 2017 Jul;
29(6):365-371.
PMID: 28697647
An indirect comparison of cisplatin-pemetrexed (CP) and cisplatin-raltitrexed (CR) was performed. The Odds Ratios of 10, 15 and 20 month survival rate and response rate were assumed as indexes of...
5.
Tassinari D, Tamburini E, Gianni L, Drudi F, Fantini M, Santelmo C, et al.
Rev Recent Clin Trials
. 2016 Jul;
11(4):317-323.
PMID: 27448518
Background: To assess the role of docetaxel plus androgen deprivation in metastatic, hormone- sensitive prostate cancer. Methods: A qualitative systematic review of literature was performed. All the randomized phase III...
6.
Mascella F, Gianni L, Affatato A, Fantini M
Int J Immunopathol Pharmacol
. 2016 May;
29(3):494-7.
PMID: 27225465
Adjuvant therapy in postmenopausal women with endocrine-responsive breast cancer (BC) is actually centered on the use of anti-aromatase inhibitors (AI). Several reports, however, are emerging in literature associating the use...
7.
Drudi F, Tassinari D, Giuliani J, Ridolfi C, Gianni L, Tamburini E, et al.
Recenti Prog Med
. 2013 Mar;
104(2):80-5.
PMID: 23535964
Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Results from randomized clinical trials confirmed the efficacy of adjuvant therapy for pancreatic cancer but did not define...
8.
Fantini M, Gianni L, Santelmo C, Drudi F, Castellani C, Affatato A, et al.
Chemother Res Pract
. 2012 Feb;
2011:125192.
PMID: 22295201
The introduction of cisplatin in cancer treatment represents an important achievement in the oncologic field. Many types of cancers are now treated with this drug, and in testicular cancer patients...
9.
Campiglio M, Bufalino R, Sandri M, Ferri E, Aiello R, de Matteis A, et al.
Breast Cancer Res Treat
. 2011 Apr;
128(1):147-54.
PMID: 21479926
Recent studies have reported the potential clinical utility for metastatic breast cancer (MBC) patients of continuing trastuzumab beyond progression. Based on those results, here the authors have examined the benefits...
10.
Fantini M, Gianni L, Tassinari D, Nicoletti S, Possenti C, Drudi F, et al.
J Oncol Pharm Pract
. 2010 Oct;
17(3):288-91.
PMID: 20926454
Capecitabine is now-a-days rapidly replacing 5-Fluorouracil in daily clinical practice. Neurologic toxicity during a treatment with fluoropyrimidines, as 5-fluorouracil, represents a well-known side-effect, largely described in literature. Central nervous system...